Pearce IP appoints biotech patent leader Grant Shoebridge PhD as Special Counsel

April 6, 2020

Specialist IP firm Pearce IP announces that leading biotech Patent Attorney Grant Shoebridge PhD, has been appointed as Special Counsel.

 

Grant is a seasoned practitioner sought by local and overseas clients for his experience in patent prosecution and opposition matters relating to life sciences. He has particular expertise regarding patent term extensions, and gene patenting.  Grant is also a litigation support expert acting in revocation proceedings in the Federal Court including in disputes relating to blockbuster antibody medicines. With Grant's contribution, Pearce IP's team has been heavily involved in 3 of the 4 biologics disputes to have hit the Australian Courts to date.

 

Grant's has a PhD relating to antibody engineering, which preceded a 12-year career in medical research.  Grant was with Shelston IP for 15 years, including many years as a Partner and Principal. 

 

Grant's work as a patent attorney is profiled in IAM Patent 1000 (2018 and 2019).  

 

Grant joins former Shelston IP superstar Dr Jennifer Enmon who commenced with Pearce IP in September 2019.  

 

 

Share on Facebook
Share on Twitter
Please reload

Biosimilars Bulletin 

November 9, 2020

Please reload

Search by tags